Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Elekta AB ser. B (EKTAb)
Elekta AB ser. B stock price live, this page displays BS EKTABs stock exchange data. View the EKTABs premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Elekta AB ser. B real time stock price chart below.
What Is the Elekta AB ser. B Stock Price Today?
The Elekta AB ser. B stock price today is 47.88.
What Is the Stock Symbol for Elekta AB ser. B?
The stock symbol for Elekta AB ser. B is "EKTABs."
What Stock Exchange Does Elekta AB ser. B Trade On?
Elekta AB ser. B is listed and trades on the BATS Europe stock exchange.
Is Elekta AB ser. B a Good Stock to Buy?
Determining whether Elekta AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKTABs quote. (ISIN: SE0000163628)
What Is the Elekta AB ser. B Stock Price Today?
The Elekta AB ser. B stock price today is 47.88.
What Is the Stock Symbol for Elekta AB ser. B?
The stock symbol for Elekta AB ser. B is "EKTABs."
What Stock Exchange Does Elekta AB ser. B Trade On?
Elekta AB ser. B is listed and trades on the BATS Europe stock exchange.
Is Elekta AB ser. B a Good Stock to Buy?
Determining whether Elekta AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKTABs quote. (ISIN: SE0000163628)
47.88
-0.08(-0.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
47.16
48.22
52 wk Range
44.50
76.30
EKTAb Scorecard
Full Analysis
Net income is expected to grow this year
High dividend Yield
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
47.1648.22
52 wk Range
44.5076.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.01%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.01%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EKTAb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
58.58
Upside
+22.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Elekta-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Elekta AB ser. B Company Profile
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Compare EKTAb to Peers and Sector
Metrics to compare | EKTAb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEKTAbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 77.2x | 25.2x | −0.5x | |
PEG Ratio | −0.94 | 0.55 | 0.00 | |
Price/Book | 2.1x | 2.3x | 2.6x | |
Price / LTM Sales | 1.0x | 2.2x | 3.0x | |
Upside (Analyst Target) | 14.9% | 31.0% | 52.6% | |
Fair Value Upside | Unlock | 15.3% | 8.7% | Unlock |
Analyst Ratings
2 Buy
5 Hold
6 Sell
Ratings:
13 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 58.58
(+22.34% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
1.11 / 1.48
Revenue / Forecast
5.16B / 5.31B
FAQ
What Is the Elekta AB ser. B (EKTAb) Stock Price Today?
The Elekta AB ser. B stock price today is 47.88.
What Stock Exchange Does Elekta AB ser. B Trade On?
Elekta AB ser. B is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Elekta AB ser. B?
The stock symbol for Elekta AB ser. B is "EKTAb."
Does Elekta AB ser. B Pay Dividends? What’s The Current Dividend Yield?
The Elekta AB ser. B dividend yield is 5.01%.
What Is the Elekta AB ser. B Market Cap?
As of today, Elekta AB ser. B market cap is 18.29B.
What Is Elekta AB ser. B's Earnings Per Share (TTM)?
The Elekta AB ser. B EPS (TTM) is 0.62.
When Is the Next Elekta AB ser. B Earnings Date?
Elekta AB ser. B will release its next earnings report on 27 Aug 2025.
From a Technical Analysis Perspective, Is EKTAb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Elekta AB ser. B Stock Split?
Elekta AB ser. B has split 2 times.
How Many Employees Does Elekta AB ser. B Have?
Elekta AB ser. B has 4536 employees.
What is the current trading status of Elekta AB ser. B (EKTAb)?
As of 22 Jun 2025, Elekta AB ser. B (EKTAb) is trading at a price of 47.88, with a previous close of 47.96. The stock has fluctuated within a day range of 47.16 to 48.22, while its 52-week range spans from 44.50 to 76.30.
What Is Elekta AB ser. B (EKTAb) Price Target According to Analysts?
The average 12-month price target for Elekta AB ser. B is SEK58.57692, with a high estimate of SEK108 and a low estimate of SEK39. 2 analysts recommend buying the stock, while 6 suggest selling, leading to an overall rating of Neutral. The stock has an +22.34% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.